Currently out of the existing stock ratings of Frank Takkinen, 89 are a BUY (96.74%), 3 are a HOLD (3.26%).

Frank Takkinen

Work Performance Price Targets & Ratings Chart

Analyst Frank Takkinen, currently employed at LAKE STREET, carries an average stock price target met ratio of 40.4% that have a potential upside of 37.77% achieved within 86 days.

Frank Takkinen’s has documented 180 price targets and ratings displayed on 21 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on CVRX, CVRx at 30-Oct-2024.

Wall Street Analyst Frank Takkinen

Analyst best performing recommendations are on APYX (APYX MEDICAL).
The best stock recommendation documented was for NOTV (INOTIV) at 5/16/2024. The price target of $2 was fulfilled within 1 day with a profit of $0.14 (6.54%) receiving and performance score of 65.42.

Average potential price target upside

of $40.5 (21.78%) on INSP (INSPIRE MEDICAL SYSTEMS).
of $10.61 (77.38%) on PAVM (PAVMED).
of $4.54 (37.74%) on SILK (SILK ROAD MEDICAL).

INSP Inspire Medical Systems NOTV Inotiv OSUR OraSure Technologies STXS Stereotaxis SNCE Science 37 Holdings APEN Apollo Endosurgery SLHG Skylight Health Group UPH Uphealth AORT Artivion PAVM PAVmed BTCY Biotricity EDAP EDAP TMS SA ICAD icad inc PROF Profound Medical Corp CVRX CVRx CLPT Clearpoint Neuro TELA Tela Bio APYX Apyx Medical BIOL BIOLASE NPCE Neuropace SILK Silk Road Medical

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Travis Steed (BAML)